Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207444

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 207444 describes TOBRAMYCIN, which is a drug marketed by Alcon Pharms Ltd, Alembic Pharms Ltd, Apotex Inc, Bausch And Lomb, Fera Pharms, Somerset Theraps Llc, Akorn Inc, Amneal Pharms, Dr Reddys Labs Sa, Lupin, Mylan, Sun Pharm, Teva Pharms Usa, Akorn, Apothecon, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Mylan Labs Ltd, Watson Labs Inc, West-ward Pharms Int, X Gen Pharms, and Xellia Pharms Aps, and is included in forty-two NDAs. It is available from seventeen suppliers. Additional details are available on the TOBRAMYCIN profile page.

The generic ingredient in TOBRAMYCIN is tobramycin sulfate. There are eighteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.
Summary for 207444
Applicant:Somerset Theraps Llc
Formulation / Manufacturing:see details
Pharmacology for NDA: 207444
Medical Subject Heading (MeSH) Categories for 207444
Suppliers and Packaging for NDA: 207444
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOBRAMYCIN tobramycin SOLUTION/DROPS;OPHTHALMIC 207444 ANDA A-S Medication Solutions 50090-4190 50090-4190-0 1 BOTTLE in 1 CARTON (50090-4190-0) > 5 mL in 1 BOTTLE
TOBRAMYCIN tobramycin SOLUTION/DROPS;OPHTHALMIC 207444 ANDA Quality Care Products, LLC 55700-747 55700-747-05 1 BOTTLE in 1 CARTON (55700-747-05) > 5 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.3%
Approval Date:Jun 28, 2017TE:ATRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.